Sponsor Pipeline

Hangzhou Sciwind Biosciences Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
3
Recruiting
3
Phase 3
1
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-07-29 NCT07734311 A Study of Econoglutide Injection in Obese Participants With Knee Osteoarthritis (KOA) Phase 3 Not Yet Recruiting
Active Trials by Phase
Phase 3
3
Phase 2
1
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07434050 A Study of XW003 in Obese Participants With Obstructive Sleep Apnea Receiving Positive… OSA - Obstructive Sleep Apnea Recruiting
NCT07387094 A Study of XW003 in Obese Participants With Obstructive Sleep Apnea But Not Receive… OSA - Obstructive Sleep Apnea Recruiting
NCT07734311 A Study of Econoglutide Injection in Obese Participants With Knee Osteoarthritis (KOA) Knee Osteoarthritis Not Yet Recruiting
Phase 2
NCT07073417 A Study to Compare XW003 Injection and Semaglutide Injection in Chinese Adults With… Obesity Active, Not Recruiting
Phase 1/2
NCT07243171 A Phase Ib/IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics and… Overweight and/or Obesity Recruiting
Disease Areas
Get alerts when Hangzhou Sciwind Biosciences Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free